Navigation Links
Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
Date:9/24/2008

f clinical data at the European Society of Cardiologists by GlaxoSmithKline on the effect of their selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor, darapladib, on a secondary biological outcome while having no effect on inflammation or LDL-C, provides encouraging validation of the anatomical importance of reducing PLA2 activity in a cardiovascular population," said Dr. Robert S. Rosenson, Director of Lipoprotein Disorders and Clinical Atherosclerosis Research at the University of Michigan. "The on-going FRANCIS trial with varespladib, which is designed to evaluate and repeat the results of previous clinical data from PLASMA and PLASMA2 in an ACS population, should provide additional data on an already validated predictor of cardiovascular risk (LDL-C) coupled with reductions in PLA2."

In previous clinical trials, varespladib, a potent and highly selective inhibitor of secretory phospholipase A2 (sPLA2), has demonstrated marked improvements in independent markers of cardiovascular risk including, a near complete suppression of the target enzyme sPLA2, clinically meaningful and statistically significant reductions in "bad" LDL cholesterol, and a reduction in C-reactive protein, a known marker of inflammation.

Presently, the company is conducting the five hundred patient FRANCIS trial (Fewer Recurrent Acute coronary events with Near-term Cardiovascular Inflammation Suppression) to assess the impact of oral varespladib on known biological markers of cardiovascular risk in ACS patients with elevated LDL and CRP. FRANCIS will also provide insight into the prevention of secondary Major Adverse Cardiovascular Events (MACE) over the duration of the six-month trial.

About Acute Coronary Syndrome

Acute coronary syndrome is a heart condition characterized by chest pain occurring at rest or upon minimal exertion. This condition is also referred to as unstable angina. If the chest pain is associated with heart muscle damage and he
'/>"/>

SOURCE Anthera Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
2. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
3. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
4. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
5. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
6. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
7. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
8. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
9. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
10. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
11. Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... released on Tuesday, April 28, 2015.  On that day, ... webcast at 10:00 a.m. Eastern Time to discuss the ... by Pat Mackin , Chairman, President and Chief ...
(Date:4/21/2015)... Md. , April 21, 2015  The ... the U.S. Food and Drug Administration that the ... effectively for the last 25 years to protect ... safe homeopathic medicines. AAHP, the industry,s trade association, ... consumers of homeopathic medicines to engage in productive ...
(Date:4/21/2015)... , April 21, 2015  TissueGene, Inc. a ... therapies in the field of cell therapy, today ... the position of Chief Operating Officer.  Mr. Newman ... Management & Clinical Operations at ZIOPHARM Oncology, a ... employing novel gene expression, control and cell technologies ...
Breaking Medicine Technology:CryoLife Announces Release Date and Teleconference Call Details for 2015 First Quarter Financial Results 2Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2TissueGene, Inc. Hires Robert Newman as Chief Operating Officer 2
(Date:4/21/2015)... This year, in recognition of IAM, the Foundation ... publish a unique awareness campaign featuring real-life patients, affected ... of May and carry the message, "Be Inspired. Use ... was chosen to encourage the general public to learn ... support our mission of educating, inspiring and connecting all ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Carinsuranceshoppingsource.com ... of analyzing comprehensive auto insurance plans . ... it provides coverage for numerous situations. The coverage limit ... expensive. Comprehensive auto insurance will protect a car against ... , Comparing quotes is no longer difficult and ...
(Date:4/21/2015)... Park, CA (PRWEB) April 21, 2015 Dr. ... team at 101 Dental Group are now offering a valuable ... crown are included in the promotional price of only $1695 ... different specials available to patients for a limited time. ... cosmetic treatments simply based on the price," dental implants ...
(Date:4/21/2015)... 21, 2015 Autocarsinsurancetips.com has released a ... cost auto insurance plans by comparing quotes. ... find the best policies in their neighborhood. The insurance ... next best offer simply by comparing different plans. ... online car insurance quotes. Insurance brokerage websites like ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Optimity ... Information Technology advisory firm that helps clients in ... today announced that the Association of Community ... Preferred Vendor. ACAP represents 58 local, not-for-profit, community-affiliated ... than 13 million people primarily enrolled in public ...
Breaking Medicine News(10 mins):Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2Health News:101 Dental Group is Now Offering a Promotion on Dental Implants 2Health News:Online Auto Insurance Quotes Can Help Clients Save Money 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2
... PLAINSBORO, N.J., July 7 As the most ... key role in their,patients, health and make more ... often than not, patients will follow these,recommendations. In ... the National Council on Patient Information and Education, ...
... Alterations in a molecular brain pathway activated by ... according to a report in the July issue of ... JAMA/Archives journals. , Expression of the cannabinoid 1 receptor ... ingredient of marijuana, is significantly reduced in the brains ...
... American Parkinson,Disease Association (APDA) has announced its 2008 ... Memorial Fellowship, a Dr. Roger Duvoisin,MD Grant, 31 ... student fellowships., David Hinkle, MD, PhD at ... that carries an $80,000 award for each of ...
... the risk seems bigger if certain painkillers are ... News) -- The widely prescribed class of antidepressants ... in the upper gastrointestinal tract, especially when taken ... study says. , Although reports of this effect ...
... Need to find a,Pennsylvania Dental Association (PDA) ... citizen living in Pennsylvania looking for reduced-fee dental,care? ... topics such as,brushing and flossing, fluoride or baby ... http://www.padental.org, is an excellent resource,providing patients this ...
... -- In a New York City metro-area first, a ... graft at NewYork-Presbyterian Hospital, the only center on the ... The new stent graft was implanted under an FDA-approved ... treat a complex form of abdominal aortic aneurysms in ...
Cached Medicine News:Health News:Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana 2Health News:American Parkinson Disease Association Awards More Than $3.7 Million to Research 2Health News:Popular Antidepressants Linked to GI Bleeding 2Health News:Popular Antidepressants Linked to GI Bleeding 3Health News:Pennsylvania Dental Association Website: A Great Resource for Pennsylvania Residents 2Health News:NYC first: Complex aneurysm treated using new fenestrated endograft stent 2
LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles....
Sabre 180 is a powerful niche generator....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: